TARELLA, Corrado
TARELLA, Corrado
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A phase I-II multicenter study on G-CSF in ALS: clinical and hematological results
2009-01-01 Moglia C; Calvo A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Corbo M; Mancardi GL; Tonali PA; Mutani R; Tarella C; Chio' A
A pilot trial of G-CSF in amyotrophic lateral sclerosis
2008-01-01 Chio' A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Moglia C; Mancardi GL; Tonali P; Calvo A; Mutani R; Corbo M; Scime’ R; D’Onofrio G; Petrini M; Melazzini M. Gualandi F; Tarella C
Clinical and Molecular Results of the Multicenter Randomized GITMO-IIL Trial in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Rituximab-Supplemented High-Dose Sequential Chemotherapy (R-HDS) Is Superior to CHOP-R in Molecular Remissions Rate, EFS and PFS
2006-01-01 Marco Ladetto; Federica de Marco; Fabio Benedetti; Umberto Vitolo; Caterina Patti; Alessandro Rambaldi; Anna Marina Liberati; Maurizio Musso; Alessandro Pulsoni; Attilio Olivieri; Enzo Pavone; Enrico Pogliani; Delia Rota Scalabrini; Andrea Gallamini; Vincenzo Callea; Irene Ricca; Mario Boccadoro; Ignazio Majolino; Paolo Corradini; Alessandro M. Gianni; Corrado Tarella
Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome
2004-01-01 Marco Ladetto; Sonia Vallet; Andreas Trojan; Maria Dell’Aquila; Luigia Monitillo; Loredana Santo; Alessandra Bertola; Patrizia Falco; Federica Cavallo; Daniela Drandi; Irene Ricca; Gloria Pagliano; Monica Astolfi; Alberto Rocci; Beata Bode; Antonio Palumbo; Corrado Tarella; Paola Omedé; Mario Boccadoro
High CR Rate and Prolonged EFS in aaIPI 2 – 3 Diffuse Large B-Cell Lymphoma Following High-Dose Sequential Chemotherapy and In Vivo Rituximab-Purged Stem Cell Autografting (R-HDS Regimen): Results of a Prospective Phase II Multicenter Study Sponsored by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)
2005-01-01 Corrado Tarella; Manuela Zanni; Massimo Di Nicola; Caterina Patti; Claudia Castellino; Alessandra Pescarollo; Valerio Zoli; Daniele Caracciolo; Marco Ladetto; Michele Magni; Liliana Devizzi; Mario Boccadoro; Marco Bregni; Paolo Corradini; Andrea Gallamini; Ignazio Majolino; Salvo Mirto; Alessandro M. Gianni
Incidence and Risk-Factors of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Chemotherapy and Autograft: A Long-Term Analysis on 307 Lymphoma Patients
2004-01-01 Davide Bono; Manuela Zanni; Irene Ricca; Daniele Caracciolo; Elisa Dama; Corrado Magnani; Paolo Gavarotti; Luciana Bergui; Alessandra Cuttica; Marco Ladetto; Mario Boccadoro; Dario Ferrero; Corrado Tarella
Long-Term Follow-Up of the Randomized GITMO/IIL Trial Comparing CHOP-Rituximab vs. High-Dose Therapy with Rituximab (R-HDS) in High Risk Follicular Lymphoma (Fl): Updated Results Suggest the Use of R-HDS as Salvage Treatment
2007-01-01 Marco Ladetto; Federica De Marco; Fabio Benedetti; Umberto Vitolo; Caterina Patti; Alessandro Rambaldi; Alessandro Pulsoni; Maurizio Musso; Anna M. Liberati; Attilio Olivieri; Andrea Gallamini; Enrico Pogliani; Delia Rota Scalabrini; Vincenzo Callea; Francesco Di Raimondo; Vincenzo Pavone; Alessandra Tucci; Sergio Cortelazzo; Alessandro Levis; Mario Boccadoro; Ignazio Majolino; Alessandro Pileri; Alessandro M. Gianni; Roberto Passera; Paolo Corradini; Corrado Tarella
Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL)
2004-01-01 Marco Ladetto; Barbara Mantoan; Federica De Marco; Berardino Pollio; Daniela Drandi; Irene Ricca; Sonia Vallet; Mara Compagno; Monica Astolfi; Maria Dell’Aquila; Roberto Francese; Gloria Pagliano; Luigia Monitillo; Giacomo Tamponi; Mario Boccadoro; Corrado Tarella
Long-Term Outcome of High-Dose Sequential Chemotherapy with Autografting (i-HDS) in Follicular Lymphoma at Diagnosis: An Update of the Prospective Multicenter Consecutive Trial of the "Gruppo Italiano Trapianto Di Midollo Osseo" (Gitmo)
2004-01-01 Marco Ladetto; Sonia Vallet; Paolo Corradini; Fabio Benedetti; Umberto Vitolo; Maurizio Martelli; Vincenzo Callea; Paolo Coser; Alessio Perrotti; Caterina Patti; Giuseppe Fioritoni; Sergio Morandi; Maurizio Musso; Renato Zambello; Monica Astolfi; Alessandro Pileri; Mario Boccadoro; Corrado Tarella
LOW INCIDENCE AND SUCCESSFUL TREATMENT OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD) AMONG 1649 PATIENTS UNDERGOING LIVER TRANSPLANTATION
2009-01-01 O. Perotto; C. Tarella; R. Passera; A. Franchello; G. Paraluppi; R. Romagnoli; C. Giordanino; D. Reggio; G. Saracco; M. Salizzoni
Non-Hodgkin’s Lymphoma Refractory to First Line Therapy: Incidence, Associated Clinical and Histological Factors, and Outcome among 503 Newly Diagnosed Patients
2007-01-01 Angela Gueli; Daniele Caracciolo; Manuela Zanni; Luciana Bergui; Paolo Gavarotti; Marco Ladetto; Andrea Filippi; Roberto Passera; Mario Boccadoro; Corrado Tarella
Rituximab-Supplemented High-Dose Sequential (HDS) Chemotherapy with Autograft Is Highly Effective in High-Risk (aaIPI 2–3) Diffuse Large B-Cell Lymphoma: Results of a Prospective Multicenter Study on 91 Consecutive Patients Treated at Diagnosis
2004-01-01 Manuela Zanni; Massimo Di Nicola; Caterina Patti; Claudia Castellino; Alessandra Pescarollo; Valerio Zoli; Daniele Caracciolo; Michele Magni; Liliana Devizzi; Mario Boccadoro; Ignazio Majolino; Marco Bregni; Andrea Gallamini; Salvo Mirto; Marco Ladetto; Alessandro M. Gianni; Corrado Tarella
Rituximab-Supplemented High-Dose Sequential Chemotherapy (HDS) Has Superior Response Rate and Event-Free Survival (EFS) Compared to R-CHOP in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Results from a Multicenter Randomized GITMO Trial
2005-01-01 Marco Ladetto; Irene Ricca; Fabio Benedetti; Umberto Vitolo; Caterina Patti; Alessandro Rambaldi; Anna Marina Liberati; Maurizio Musso; Alessandro Pulsoni; Attilio Olivieri; Enzo Pavone; Enrico Pogliani; Delia Rota Scalabrini; Andrea Gallamini; Vincenzo Callea; Barbara Mantoan; Mario Boccadoro; Ignazio Majolino; Paolo Corradini; Alessandro M. Gianni; Corrado Tarella
Sequential Brief Chemo-Immunotherapy FND + Rituximab in Elderly Patients with Advanced Stage Follicular Lymphoma (FL): High Clinical and Molecular Remission Rate Associated with a Prolonged Failure-Free Survival
2004-01-01 Umberto Vitolo; Carola Boccomini; Marco Ladetto; Enrico Pogliani; Delia Rota Scalabrini; Corrado Tarella; Claudia Castellino; Massimo Aglietta; Monica Astolfi; Andrea Carpaneto; Paolo Corradini; Antonella Darbesio; Alberto De Crescenzo; Alessandro Levis; Anna Marina Liberati; Sergio Morandi; Lorella Orsucci; Patrizia Pregno; Luigi Rigacci; Fausto Rossini; Anna Tonso; Eugenio Gallo
Telomerase Inhibitor BIBR1532 Induces Telomere Shortening and Growth Inhibition in Extra-Germinal Center (GC)-Derived Lymphoid Cell Lines
2004-01-01 Marco Ladetto; Irene Ricca; Mara Compagno; Dario Ferrero; Alberto Rocci; Maria Dell’Aquila; Paola Omedè; Roberto Francese; Federica De Marco; Sonia Vallet; Loredana Santo; Daniela Drandi; Monica Astolfi; Mario Boccadoro; Corrado Tarella
Telomere Length Identifies Two Distinct Populations with Different Outcome among VH-Unmutated CLL Patients
2005-01-01 Irene Ricca; Alberto Rocci; Daniela Drandi; Mara Compagno; Roberto Francese; Paola Omedè; Loredana Santo; Michela Rosace; Federica De Marco; Monica Astolfi; Chiara Lobetti Bodoni; Maria Dell’Aquila; Sonia Vallet; Luciana Bergui; Andrea Gallamini; Carlo Marinone; Mario Boccadoro; Corrado Tarella; Marco Ladetto
Telomere Length Is An Independent Predictor of Survival, Treatment Requirement and Richter’s Syndrome Transformation in Chronic Lymphocytic Leukemia
2008-01-01 Davide Rossi; Chiara Lobetti Bodoni; Elisa Genuardi; Luigia Monitillo; Daniela Drandi; Clara Deambrogi; Michaela Cerri; Irene Ricca; Alberto Rocci; Simone Ferrero; Elisa Bernocco; Daniela Capello; Lorenzo De Paoli; Luciana Bergui; Michela Boi; Paola Omedè; Massimo Massaia; Corrado Tarella; Roberto Passera; Mario Boccadoro; Gianluca Gaidano; Marco Ladetto
Telomere Length of Hematopoietic Cells Following Autologous and Allogeneic Stem Cell Transplant (SCT) Reflects That of Grafted Cells: Can the Transplant of Younger Stem Cells Be Exploited To Rejuvenate Hematopoiesis?
2007-01-01 Alberto Rocci; Marco Ruella; Irene Ricca; Cristiana Carniti; Manuela Zanni; Chiara Lobetti Bodoni; Marco Ladetto; Daniele Caracciolo; Mario Boccadoro; Paolo Corradini; Corrado Tarella
The Degree of Telomere Loss in Hematopoietic Cells Correlates with the Risk of Secondary Myelodysplasia/Acute Leukemia Development Following Autologous Stem Cell Transplantation
2007-01-01 Irene Ricca; Alberto Rocci; Marco Ruella; Manuela Zanni; Daniele Caracciolo; Marco Ladetto; Mario Boccadoro; Dario Ferrero; Corrado Tarella
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A phase I-II multicenter study on G-CSF in ALS: clinical and hematological results | 2009 | Moglia C; Calvo A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Corbo M; Mancardi GL; Tonali PA; Mutani R; Tarella C; Chio' A | |
| A pilot trial of G-CSF in amyotrophic lateral sclerosis | 2008 | Chio' A; Mora G; Caponnetto C; Siciliano G; Sabatelli M; La Bella V; Silani V; Moglia C; Mancardi GL; Tonali P; Calvo A; Mutani R; Corbo M; Scime’ R; D’Onofrio G; Petrini M; Melazzini M. Gualandi F; Tarella C | |
| Clinical and Molecular Results of the Multicenter Randomized GITMO-IIL Trial in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Rituximab-Supplemented High-Dose Sequential Chemotherapy (R-HDS) Is Superior to CHOP-R in Molecular Remissions Rate, EFS and PFS | 2006 | Marco Ladetto; Federica de Marco; Fabio Benedetti; Umberto Vitolo; Caterina Patti; Alessandro Rambaldi; Anna Marina Liberati; Maurizio Musso; Alessandro Pulsoni; Attilio Olivieri; Enzo Pavone; Enrico Pogliani; Delia Rota Scalabrini; Andrea Gallamini; Vincenzo Callea; Irene Ricca; Mario Boccadoro; Ignazio Majolino; Paolo Corradini; Alessandro M. Gianni; Corrado Tarella | |
| Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome | 2004 | Marco Ladetto; Sonia Vallet; Andreas Trojan; Maria Dell’Aquila; Luigia Monitillo; Loredana Santo; Alessandra Bertola; Patrizia Falco; Federica Cavallo; Daniela Drandi; Irene Ricca; Gloria Pagliano; Monica Astolfi; Alberto Rocci; Beata Bode; Antonio Palumbo; Corrado Tarella; Paola Omedé; Mario Boccadoro | |
| High CR Rate and Prolonged EFS in aaIPI 2 – 3 Diffuse Large B-Cell Lymphoma Following High-Dose Sequential Chemotherapy and In Vivo Rituximab-Purged Stem Cell Autografting (R-HDS Regimen): Results of a Prospective Phase II Multicenter Study Sponsored by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) | 2005 | Corrado Tarella; Manuela Zanni; Massimo Di Nicola; Caterina Patti; Claudia Castellino; Alessandra Pescarollo; Valerio Zoli; Daniele Caracciolo; Marco Ladetto; Michele Magni; Liliana Devizzi; Mario Boccadoro; Marco Bregni; Paolo Corradini; Andrea Gallamini; Ignazio Majolino; Salvo Mirto; Alessandro M. Gianni | |
| Incidence and Risk-Factors of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Chemotherapy and Autograft: A Long-Term Analysis on 307 Lymphoma Patients | 2004 | Davide Bono; Manuela Zanni; Irene Ricca; Daniele Caracciolo; Elisa Dama; Corrado Magnani; Paolo Gavarotti; Luciana Bergui; Alessandra Cuttica; Marco Ladetto; Mario Boccadoro; Dario Ferrero; Corrado Tarella | |
| Long-Term Follow-Up of the Randomized GITMO/IIL Trial Comparing CHOP-Rituximab vs. High-Dose Therapy with Rituximab (R-HDS) in High Risk Follicular Lymphoma (Fl): Updated Results Suggest the Use of R-HDS as Salvage Treatment | 2007 | Marco Ladetto; Federica De Marco; Fabio Benedetti; Umberto Vitolo; Caterina Patti; Alessandro Rambaldi; Alessandro Pulsoni; Maurizio Musso; Anna M. Liberati; Attilio Olivieri; Andrea Gallamini; Enrico Pogliani; Delia Rota Scalabrini; Vincenzo Callea; Francesco Di Raimondo; Vincenzo Pavone; Alessandra Tucci; Sergio Cortelazzo; Alessandro Levis; Mario Boccadoro; Ignazio Majolino; Alessandro Pileri; Alessandro M. Gianni; Roberto Passera; Paolo Corradini; Corrado Tarella | |
| Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL) | 2004 | Marco Ladetto; Barbara Mantoan; Federica De Marco; Berardino Pollio; Daniela Drandi; Irene Ricca; Sonia Vallet; Mara Compagno; Monica Astolfi; Maria Dell’Aquila; Roberto Francese; Gloria Pagliano; Luigia Monitillo; Giacomo Tamponi; Mario Boccadoro; Corrado Tarella | |
| Long-Term Outcome of High-Dose Sequential Chemotherapy with Autografting (i-HDS) in Follicular Lymphoma at Diagnosis: An Update of the Prospective Multicenter Consecutive Trial of the "Gruppo Italiano Trapianto Di Midollo Osseo" (Gitmo) | 2004 | Marco Ladetto; Sonia Vallet; Paolo Corradini; Fabio Benedetti; Umberto Vitolo; Maurizio Martelli; Vincenzo Callea; Paolo Coser; Alessio Perrotti; Caterina Patti; Giuseppe Fioritoni; Sergio Morandi; Maurizio Musso; Renato Zambello; Monica Astolfi; Alessandro Pileri; Mario Boccadoro; Corrado Tarella | |
| LOW INCIDENCE AND SUCCESSFUL TREATMENT OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD) AMONG 1649 PATIENTS UNDERGOING LIVER TRANSPLANTATION | 2009 | O. Perotto; C. Tarella; R. Passera; A. Franchello; G. Paraluppi; R. Romagnoli; C. Giordanino; D. Reggio; G. Saracco; M. Salizzoni | |
| Non-Hodgkin’s Lymphoma Refractory to First Line Therapy: Incidence, Associated Clinical and Histological Factors, and Outcome among 503 Newly Diagnosed Patients | 2007 | Angela Gueli; Daniele Caracciolo; Manuela Zanni; Luciana Bergui; Paolo Gavarotti; Marco Ladetto; Andrea Filippi; Roberto Passera; Mario Boccadoro; Corrado Tarella | |
| Rituximab-Supplemented High-Dose Sequential (HDS) Chemotherapy with Autograft Is Highly Effective in High-Risk (aaIPI 2–3) Diffuse Large B-Cell Lymphoma: Results of a Prospective Multicenter Study on 91 Consecutive Patients Treated at Diagnosis | 2004 | Manuela Zanni; Massimo Di Nicola; Caterina Patti; Claudia Castellino; Alessandra Pescarollo; Valerio Zoli; Daniele Caracciolo; Michele Magni; Liliana Devizzi; Mario Boccadoro; Ignazio Majolino; Marco Bregni; Andrea Gallamini; Salvo Mirto; Marco Ladetto; Alessandro M. Gianni; Corrado Tarella | |
| Rituximab-Supplemented High-Dose Sequential Chemotherapy (HDS) Has Superior Response Rate and Event-Free Survival (EFS) Compared to R-CHOP in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Results from a Multicenter Randomized GITMO Trial | 2005 | Marco Ladetto; Irene Ricca; Fabio Benedetti; Umberto Vitolo; Caterina Patti; Alessandro Rambaldi; Anna Marina Liberati; Maurizio Musso; Alessandro Pulsoni; Attilio Olivieri; Enzo Pavone; Enrico Pogliani; Delia Rota Scalabrini; Andrea Gallamini; Vincenzo Callea; Barbara Mantoan; Mario Boccadoro; Ignazio Majolino; Paolo Corradini; Alessandro M. Gianni; Corrado Tarella | |
| Sequential Brief Chemo-Immunotherapy FND + Rituximab in Elderly Patients with Advanced Stage Follicular Lymphoma (FL): High Clinical and Molecular Remission Rate Associated with a Prolonged Failure-Free Survival | 2004 | Umberto Vitolo; Carola Boccomini; Marco Ladetto; Enrico Pogliani; Delia Rota Scalabrini; Corrado Tarella; Claudia Castellino; Massimo Aglietta; Monica Astolfi; Andrea Carpaneto; Paolo Corradini; Antonella Darbesio; Alberto De Crescenzo; Alessandro Levis; Anna Marina Liberati; Sergio Morandi; Lorella Orsucci; Patrizia Pregno; Luigi Rigacci; Fausto Rossini; Anna Tonso; Eugenio Gallo | |
| Telomerase Inhibitor BIBR1532 Induces Telomere Shortening and Growth Inhibition in Extra-Germinal Center (GC)-Derived Lymphoid Cell Lines | 2004 | Marco Ladetto; Irene Ricca; Mara Compagno; Dario Ferrero; Alberto Rocci; Maria Dell’Aquila; Paola Omedè; Roberto Francese; Federica De Marco; Sonia Vallet; Loredana Santo; Daniela Drandi; Monica Astolfi; Mario Boccadoro; Corrado Tarella | |
| Telomere Length Identifies Two Distinct Populations with Different Outcome among VH-Unmutated CLL Patients | 2005 | Irene Ricca; Alberto Rocci; Daniela Drandi; Mara Compagno; Roberto Francese; Paola Omedè; Loredana Santo; Michela Rosace; Federica De Marco; Monica Astolfi; Chiara Lobetti Bodoni; Maria Dell’Aquila; Sonia Vallet; Luciana Bergui; Andrea Gallamini; Carlo Marinone; Mario Boccadoro; Corrado Tarella; Marco Ladetto | |
| Telomere Length Is An Independent Predictor of Survival, Treatment Requirement and Richter’s Syndrome Transformation in Chronic Lymphocytic Leukemia | 2008 | Davide Rossi; Chiara Lobetti Bodoni; Elisa Genuardi; Luigia Monitillo; Daniela Drandi; Clara Deambrogi; Michaela Cerri; Irene Ricca; Alberto Rocci; Simone Ferrero; Elisa Bernocco; Daniela Capello; Lorenzo De Paoli; Luciana Bergui; Michela Boi; Paola Omedè; Massimo Massaia; Corrado Tarella; Roberto Passera; Mario Boccadoro; Gianluca Gaidano; Marco Ladetto | |
| Telomere Length of Hematopoietic Cells Following Autologous and Allogeneic Stem Cell Transplant (SCT) Reflects That of Grafted Cells: Can the Transplant of Younger Stem Cells Be Exploited To Rejuvenate Hematopoiesis? | 2007 | Alberto Rocci; Marco Ruella; Irene Ricca; Cristiana Carniti; Manuela Zanni; Chiara Lobetti Bodoni; Marco Ladetto; Daniele Caracciolo; Mario Boccadoro; Paolo Corradini; Corrado Tarella | |
| The Degree of Telomere Loss in Hematopoietic Cells Correlates with the Risk of Secondary Myelodysplasia/Acute Leukemia Development Following Autologous Stem Cell Transplantation | 2007 | Irene Ricca; Alberto Rocci; Marco Ruella; Manuela Zanni; Daniele Caracciolo; Marco Ladetto; Mario Boccadoro; Dario Ferrero; Corrado Tarella |